Actelion Ltd. CFO Actively Hunting for M&A Opportunities

(Reuters) - Actelion Ltd, Europe's biggest biotech firm, is looking at possible acquisitions but it will not pay an overly high price, the Swiss company's finance chief told Reuters on Tuesday.

"We are actively looking for M&A opportunities," Chief Financial Officer Andre Muller said in an interview. "However, we will remain disciplined especially in this M&A frenzy that we've seen in the recent past."

Actelion earlier on Tuesday raised its full-year guidance after strong sales of its new heart and lung drug helped its first-quarter earnings exceed analysts' estimates.

Help employers find you! Check out all the jobs and post your resume.

Back to news